Pharmaceutical composition for treatment and/or prevention of cancer

Details for Australian Patent Application No. 2011211699 (hide)

Owner Toray Industries, Inc.

Inventors Kobayashi, Shinichi; Okano, Fumiyoshi; Saito, Takanori

Agent Pizzeys

Pub. Number AU-A-2011211699

PCT Pub. Number WO2011/096534

Priority 2010-023454 04.02.10 JP; 2010-183162 18.08.10 JP

Filing date 4 February 2011

Wipo publication date 11 August 2011

International Classifications

C12N 15/02 Mutation or genetic engineering - Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 Antineoplastic agents

C07K 16/18 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C07K 16/46 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

C12N 15/09 Mutation or genetic engineering - Recombinant DNA-technology

Event Publications

23 August 2012 PCT application entered the National Phase

  PCT publication WO2011/096534 Priority application(s): WO2011/096534

30 August 2012 Amendment Made

  The nature of the amendment is: Amend the invention title to read Pharmaceutical composition for treating and/or preventing cancer

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011211700-Pharmaceutical agent for treatment and/or prevention of cancer

2011211698-Pharmaceutical composition for treatment and/or prevention of cancer